Mar 30 |
ProSomnus, Inc. Common Stock (NASDAQ:OSA) Q4 2023 Earnings Call Transcript
|
Mar 27 |
ProSomnus, Inc. (OSA) Q4 2023 Earnings Call Transcript
|
Mar 26 |
ProSomnus reports Q4 results
|
Mar 26 |
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
|
Mar 16 |
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
|
Feb 23 |
Top 4 Health Care Stocks That Are Preparing To Pump This Month
|
Feb 22 |
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
|
Feb 20 |
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
|
Jan 30 |
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
|
Jan 29 |
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
|